ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 13 of 32
JMBS 2022, 7(6): 89–94
Clinical Medicine

Neuropathic Pain in Ankylosing Spondilitis and Peculiarities of Psychopathological Response

Kedyk I. O.

The purpose of the work was to study the features of psychopathological symptoms in ankylosing spondylitis with and without neuropathic pain. Materials and methods. We clinically examined 142 patients treated between 2019 and 2022 who were diagnosed with ankylosing spondylitis according to the modified New York criteria. These patients were divided into two groups: the first group had the signs of neuropathic pain; the second group had no signs. The study of the psycho-emotional sphere was carried out using the The Zung Self-Rating Depression Scale, scales for assessing the level of personal and reactive anxiety by S. Spilberger, and the Mini Mental State Examination questionnaire was used to determine cognitive function. Results and discussion. It was found that the basis of psychopathological reactions in ankylosing spondylitis are mild and moderate depressive and anxiety symptoms: the average score on The Zung Self-Rating Depression Scale in patients without neuropathic pain was 48.1 ± 13.1 points, and in patients with neuropathic pain – 58.1 ± 4.6 points (p<0.01). 28.9% had no signs of depression, 45.1% showed signs of mild depression, and 26.0% – moderate depression. In 41.5% of patients without neuropathic pain, no signs of depression were found, in 40.4% – mild depression, in 18.1% – moderate, in patients with neuropathic pain – 4.2%, 54.2%, and 41.6%, respectively. The average value of the reactive anxiety index in the examined was 47.2 ± 12.2 points, in patients without neuropathic pain – 45.5 ± 12.7 points, in patients with neuropathic pain – 50.4 ± 10.5 points (p<0.05); personal anxiety indicator was 45.5 ± 10.1, 43.7 ± 10.6 and 49.0 ± 8.2 points, respectively (p<0.05). A low level of reactive anxiety in patients with neuropathic pain was found in 2.1%, without neuropathic pain – in 13.8% (p<0.05); medium – respectively in 31.3% versus 36.2% (p>0.05), high – respectively in 66.6% versus 50.0% (p<0.05). There were significantly more patients with low levels of personal anxiety among those who did not have neuropathic pain – 20.2% versus 6.3% (p<0.05), and with high levels – among patients with neuropathic pain: 56.2% versus 38.3% (p<0.05). The average value of the Mini Mental State Examination index in all patients was 27.46 ± 1.77 points; in patients with neuropathic pain – 26.29 ± 1.39 points, without neuropathic pain – 28.06 ± 1.64 points (p<0.01). Conclusion. Correlation analysis made it possible to establish the presence of significant correlations between expressiveness of neuropathic pain and depression and anxiety. Depressive and anxious manifestations in ankylosing spondylitis reflect psychopathological reactions to severe disease, pain and somatic discomfort, and personal anxiety as a stable personality characteristic, in ankylosing spondylitis patients primarily reflects the formation of patho-characteristic features as a result of long-term somatogenic influence. Cognitive impairment is probably mediated by depressive and anxiety symptoms and the influence of pain syndrome. The presence of a neuropathic component of the pain syndrome is a factor that aggravates the state of the psycho-emotional sphere, which justifies the feasibility of prescribing psychopharmacological therapy for ankylosing spondylitis

Keywords: ankylosing spondylitis, neuropathic pain, depression, anxiety, cognitive impairment

Full text: PDF (Ukr) 274K

  1. Wenker KJ, Quint JM. Ankylosing Spondylitis. StatPearls Publishing; 2022. PMID: 29261996
  2. Wang R, Ward MM. Epidemiology of axial spondyloarthritis: an update. Curr Opin Rheumatol. 2018;30(2):137-43. PMID: 29227352. PMCID: PMC5811203. doi: 10.1097/BOR.0000000000000475
  3. Crossfield SSR, Marzo-Ortega H, Kingsbury SR, Pujades-Rodriguez M, Conaghan PG. Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades. RMD Open. 2021;7(3):e001888. PMID: 34887345. PMCID: PMC8663075. doi: 10.1136/rmdopen-2021-001888
  4. Proft F, Poddubnyy D. Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria. Ther Adv Musculoskelet Dis. 2018;10(5-6):129-39. PMID: 29942364. PMCID: PMC6009093. doi: 10.1177/1759720X18773726
  5. Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;3(1):17002. PMID: 28205574. PMCID: PMC5371025. doi: 10.1038/NRDP.2017.2
  6. Szok D, Tajti J, Nyári A, Vécsei L, Trojano L. Therapeutic approaches for peripheral and central neuropathic pain. Behav Neurol. 2019;9:1-13. PMID: 31871494. PMCID: PMC6906810. doi: 10.1155/2019/8685954
  7. Bates D, Schultheis BC, Hanes MC, Jolly SM, Chakravarthy KV, Deer TR, et al. A comprehensive algorithm for management of neuropathic pain. Pain Med. 2019;20:S2-S12. PMID: 31152178. PMCID: PMC6544553. doi: 10.1093/PM/PNZ075
  8. Dunn JS, Nagi SS, Mahns DA. Minocycline reduces experimental muscle hyperalgesia induced by repeated nerve growth factor injections in humans: a placebo-controlled double-blind drug-crossover study. Eur J Pain. 2020;24(6):1138-50. PMID: 32170964. doi: 10.1002/EJP.1558
  9. Zarepour L, Gharaylou Z, Hadjighassem M, Shafaghi L, Majedi H, Behzad E, et al. Preliminary study of analgesic effect of bumetanide on neuropathic pain in patients with spinal cord injury. J Clin Neurosci. 2020;81:477-84. PMID: 33222966. doi: 10.1016/J.JOCN.2020.10.010
  10. Park JY, Howren AM, Zusman EZ, Esdaile JM, De Vera MA. The incidence of depression and anxiety in patients with ankylosing spondylitis: a systematic review and meta-analysis. BMC Rheumatol. 2020;4:12. PMID: 32159073. PMCID: PMC7050143. doi: 10.1186/s41927-019-0111-6
  11. Webers C, Vanhoof L, Leue C, Boonen A, Köhler S. Depression in ankylosing spondylitis and the role of disease-related and contextual factors: a cross-sectional study. Arthritis Res Ther. 2019;21:215. PMID: 31639012. PMCID: PMC6805406. doi: 10.1186/s13075-019-1995-7
  12. Linden SVD, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum. 1984;27(4):361-68. PMID: 6231933. doi: 10.1002/art.1780270401
  13. Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001;92(1-2):147-57. PMID: 11323136. doi: 10.1016/s0304-3959(00)00482-6
  14. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1-2):29-36. PMID: 15733628. doi: 10.1016/j.pain.2004.12.010
  15. Zung WW. A self-rating depression scale. Arch General Psychiatry. 1965;12(1):63-70. PMID: 14221692. doi: 10.1001/archpsyc.1965.01720310065008
  16. Spielberger CD. Test anxiety inventory: Preliminary professional manual. Palo Alto, CA: Consulting Psychologist Press; 1980.
  17. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res. 1975;12(3):189-98. PMID: 1202204. doi: 10.1016/0022-3956(75)90026-6
  18. Ma T, Geng Y, Li P. Depression in patients with ankylosing spondylitis. Rheumatol Autoimmun. 2022;2:69-75. doi: 10.1002/rai2.12020
  19. Zhao S, Thong D, Miller N, Duffield SJ, Hughes DM, Chadwick L, et al. The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis. Arthritis Res Ther. 2018;20(1):140. PMID: 29996916. PMCID: PMC6042424. doi: 10.1186/s13075-018-1644-6
  20. Fang ML, Wu CS, Weng LC, Huang HL. Factors associated with depressive symptoms in patients with ankylosing spondylitis in Northern Taiwan. PLoS One. 2019;14(10):e0224298. PMID: 31648243. PMCID: PMC6812870. doi: 10.1371/journal.pone.0224298
  21. Reddy KN, Sabu N, Pandey N, Raut A, Joag K, Patil P. Anxiety and depression among patients with axial spondyloarthritis. Eur J Rheumatol. 2021; 9(1): 8-13. PMID: 35110131. doi: 10.5152/eurjrheum.2021.21022
  22. Zou Q, Jiang Y, Mu F, Shi Y, Fang Y. Correlation of axial spondyloarthritis with anxiety and depression. Med Sci Monit. 2016;22:3202-08. PMID: 27611598. PMCID: PMC5021017. doi: 10.12659/MSM.897232
  23. Ben Tekaya A, Mahmoud I, Hamdı I, Hechmı S, Saıdane O, Tekaya R, et al. Depression and anxiety in spondyloarthritis: Prevalence and relationship with clinical parameters and self-reported outcome measures. Turk Psikiyatri Derg. 2019;130(2): 90-98. PMID: 31487374
  24. Vitturi B, Suriano E, Pereira de Sousa A, Torigoe, D. Cognitive Impairment in Patients with Ankylosing Spondylitis. Canadian J Neurolog Sci. 2020;47(2):219-225. PMID: 31928545. doi: 10.1017/cjn.2020.14
  25. Moriarty O, Ruane N, O'Gorman D, Maharaj CH, Mitchell C, Sarma KM, et al. Cognitive Impairment in Patients with Chronic Neuropathic or Radicular Pain: An Interaction of Pain and Age. Front Behav Neurosci. 2017;13(11):100. PMID: 28659771. PMCID: PMC5468384. doi: 10.3389/fnbeh.2017.00100